- Home
- Products
SOLIRIS (eculizumab)
SOLIRIS (eculizumab)
- Medicine Name: Soliris
- Generic Name: Eculizumab
- Dosage Form & Strength: 30 mL single-use vial (10 mg/mL concentration)
- Manufactured By: Alexion Pharmaceuticals, Inc.
Soliris (eculizumab) is a complement inhibitor used in the treatment of rare, life-threatening disorders involving uncontrolled complement activation:
- Paroxysmal Nocturnal Hemoglobinuria (PNH): Reduces hemolysis in patients with PNH
- Atypical Hemolytic Uremic Syndrome (aHUS): Inhibits complement-mediated thrombotic microangiopathy (TMA)
It is administered under the supervision of a healthcare professional through intravenous infusion, following a prescribed dosing schedule.
- Risk of Meningococcal Infection: Soliris increases susceptibility to life-threatening meningococcal infections. Monitor closely for symptoms such as headache, fever, or neck stiffness. Vaccination is recommended prior to treatment initiation.
- Infection Risk: Avoid administration in patients with active systemic infections. Evaluate and manage promptly if an infection is suspected.
- Infusion Reactions: Discontinue treatment immediately in the event of a severe infusion-related reaction. Provide appropriate medical support.
- Monitoring After Discontinuation: Monitor patients for at least 8 weeks post-discontinuation for signs of hemolysis.
- Pregnancy & Lactation: Soliris may harm an unborn child. Use effective contraception during treatment. Breastfeeding is not advised.
To Import Soliris into India, the following documents are required:
- A valid prescription from a registered specialist (e.g., hematologist, nephrologist)
- Diagnostic reports confirming the indication (PNH or aHUS)
- Government-issued ID proof of the patient
Order Confirmation:
Processing begins only after all documentation and import permit (if applicable) is received.
Availability in India:
Soliris is not commercially available in India. GlobalRareMeds facilitates access through the Named Patient Import Program, sourcing the medicine legally from approved international suppliers.
GlobalRareMeds sources Soliris (Eculizumab) from certified suppliers in the USA, Europe, and Canada.
Orders are fulfilled via our Ambernath, Thane District logistics hub and dispatched to all major cities across India including Mumbai, Delhi, Hyderabad, Bengaluru, Pune, Chennai, Ahmedabad, and more.
For inquiries, support, or order placement:
📧 info@globalraremeds.com
📞 +91-99675 15602
📱 WhatsApp: +91-99675 15602
What is the generic name of Soliris?
Eculizumab.
Who manufactures Soliris?
Soliris is manufactured by Alexion Pharmaceuticals, Inc.
Is Soliris FDA approved?
Yes. Soliris received U.S. FDA approval on September 23, 2011.
What is the form and strength of Soliris available?
Soliris is supplied as a 300 mg single-use vial, containing 30 mL of a 10 mg/mL sterile, preservative-free solution for IV infusion.
What conditions is Soliris used for?
Soliris is used for treating Paroxysmal Nocturnal Hemoglobinuria (PNH) and Atypical Hemolytic Uremic Syndrome (aHUS).
How can I get Soliris in India?
With a valid prescription, Soliris can be imported legally through GlobalRareMeds under the Named Patient Program.
What is the cost of Soliris in India?
Due to high variability in international pricing and import costs, contact us directly for current rates.
Can Soliris be made available in other countries?
 Yes. We support deliveries to SAARC and Gulf countries including Nepal, Bangladesh, UAE, and Sri Lanka.
Is it safe to buy Soliris online in India?
Yes, when sourced through authorized and compliant importers like GlobalRareMeds.
How should Soliris be stored?
Store refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light and store in the original carton.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
